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Diagnostic Value of lingual 
Tonsillectomy in Unknown Primary 
head and neck carcinoma 
identification after a negative 
clinical Workup and Positron 
emission Tomography-computed 
Tomography
Chad K. Sudoko1, Marc A. Polacco2, Benoit J. Gosselin2,3 and Joseph A. Paydarfar 2,3*
1 Geisel School of Medicine at Dartmouth College, Hanover, NH, United States, 2 Section of Otolaryngology, Audiology & 
Maxillofacial Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States, 3 Norris Cotton Cancer Center, 
Lebanon, NH, United States
Objective: Diagnostic rates of unknown primary head and neck carcinoma (UPHNC) 
using lingual tonsillectomy (LT) are highly variable. This study sought to determine the 
diagnostic value of LT in UPHNC identification using strict inclusion criteria and definitions 
to produce a more accurate estimate of diagnosis rate.
Methods: In this retrospective chart review, records of patients who underwent LT for 
UPHNC were reviewed. Inclusion criteria included absence of suspicious findings on 
physical exam and positron emission tomography-computed tomography as well as 
negative biopsies after panendoscopy and palatine tonsillectomy. Following inclusion 
criteria, 16 patients were reviewed. A systematic literature review on LT for the workup 
of CUP was also performed.
results: LT was performed using transoral robotic surgery (TORS), transoral laser 
microsurgery (TLM), or transoral microsurgery with cautery (TMC). Following LT, primary 
tumor was identified in 4 patients out of 16. Detection rate by technique was 1/6, 2/7, 
and 1/3 for TORS, TLM, and TMC respectively. Postoperative bleeding occurred in three 
patients (19%); however, this was not related to the LT. Following literature review, 12 
studies were identified; however, only 3 had enough data to compare against. All three 
studies had a cohort with suspicious findings on clinical exam. A total of 34 patients 
had a negative workup, with no suspicious findings on clinical exam and subsequently 
received an LT.
conclusion: This study suggests that LT should be considered initially in the diagnostic 
algorithm for UPHNC. This study can increase the patient size in this cohort by approx-
imately 47%.
Keywords: squamous cell carcinoma, unknown primary, lingual tonsillectomy, transoral robotic surgery, transoral 
laser microsurgery
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sUMMarY
•	 The	rate	of	unknown	primary	detection	from	LT	in	the	liter-
ature	 ranges	 from	18	 to	90%,	a	 range	which	may	 stem	 from	
small	cohorts	and	heterogeneity	of	inclusion	criteria.
•	 The	rate	of	unknown	primary	detection	from	LT	in	this	study	
was	25%.
•	 Bleeding	was	the	most	common	complication	and	occurred	in	
19%	of	cases.
•	 LT	 should	 be	 advocated	 in	 the	 diagnostic	 algorithm	 for	
UPHNC	to	improve	early	detection	rates.
inTrODUcTiOn
Unknown	primary	head	and	neck	carcinoma	(UPHNC)	presents	
as	metastatic	malignancy	identified	in	a	cervical	lymph	node	with-
out	 identification	of	primary	origin	on	diagnostic	 examination	
(1,	2).	When	pathology	is	consistent	with	p16	positive	squamous	
cell	carcinoma	(SCC),	the	oropharynx	is	the	most	likely	source	of	
origin	(3,	4).	Representing	approximately	2–5%	of	all	new	head	
and	neck	malignancies,	the	primary	site	is	eventually	isolated	to	
the	palatine	or	lingual	tonsils	in	80–90%	of	patients	(5,	6).	When	
encountered,	the	first	step	in	the	work	up	of	UPHNC	is	clinical	
evaluation	involving	a	full	history	and	physical	exam,	including	
flexible	fiber	optic	laryngoscopy.	Positron	emission	tomography-
computed	tomography	(PET-CT)	is	often	performed	and	carries	
a	 diagnostic	 rate	 of	 7–38%	 (7,	 8).	 Once	 imaging	 is	 complete,	
panendoscopy	with	tumor	mapping	is	performed,	with	or	without	
palatine	tonsillectomy.	Reported	diagnostic	rates	of	tumor	map-
ping	 are	 approximately	 20–50%	when	biopsies	 can	be	 targeted	
with	 PET-CT;	 however,	 diagnostic	 rates	 markedly	 decrease	 to	
9–29%	when	PET-CT	is	negative	(5,	6,	9,	10).
The	treatment	of	UPHNC	entails	neck	dissection	plus	chemo-
radiation	 (CRT),	 neck	 dissection	 plus	 radiation,	 primary	CRT,	
or	primary	 radiation.	Because	a	primary	 site	 cannot	be	 identi-
fied,	 radiation	 fields	 are	 broad	 to	 target	 the	 entire	 oropharynx	
and	 hypopharynx,	 increasing	 risk	 of	 developing	 dysphagia,	
odynophagia,	xerostomia,	and	dysphonia	(1).	Some	studies	have	
also	suggested	decreased	survival	in	patients	treated	for	UPHNC	
(11).	When	tumor	location	can	be	identified,	radiotherapy	can	be	
targeted	and	intensity	modulated	to	reduce	side	effects	while	still	
providing	adequate	treatment	doses	(12,	13).
The	importance	of	reducing	morbidity	through	primary	site	
identification	has	spurred	investigations	into	diagnostic	protocol	
improvement.	 The	 addition	 of	 lingual	 tonsillectomy	 (LT)	 has	
become	an	increasingly	prevalent	adjunct	due	to	improved	diag-
nostic	rates	and	low	morbidity.	In	recent	years,	these	procedures	
have	been	performed	using	transoral	laser	microsurgery	(TLM)	
and	transoral	robotic	surgery	(TORS)	as	they	enhance	both	visu-
alization	and	mobility	of	tissue	compared	with	traditional	tran-
soral	instruments	(14).	With	the	addition	of	palatine	and/or	LT,	
primary	site	detection	rates	have	been	reported	as	high	as	94%	in	
addition	to	providing	100%	5-year	disease	free	survival	rates	(15).	
With	TORS,	LT	alone	has	reported	diagnostic	rates	of	18–90%	
(1,	14,	16–19).	This	broad	variation	in	diagnostic	rates	 is	 likely	
due	to	the	relative	infrequency	of	UPHNC;	studies	assessing	the	
diagnostic	utility	of	LT	contain	small	cohorts	as	well	as	differences	
in	preoperative	assessment,	imaging,	and	surgical	technique.	We	
hypothesize	 that,	with	adherence	 to	 strict	 inclusion	criteria	 for	
unknown	primary	based	on	negative	clinical	evaluation	as	well	
as	PET-CT	imaging	without	any	suggestion	of	primary	location,	
LT	would	result	in	a	lower	UPHNC	detection	rate	than	what	is	
reported	in	most	of	the	existing	literature.	In	addition,	we	have	
performed	a	systematic	review	of	literature	to	compare	our	results	
with	similar	studies.
MaTerials anD MeThODs
Approval	 for	 this	 study	was	obtained	 through	 the	Dartmouth-
Hitchcock	Institutional	Review	Board.	We	reviewed	the	medical	
records	of	all	patients	presenting	between	February	2010	and	May	
2017	who	had	undergone	LT	and	biopsy-proven	metastatic	SCC	
to	cervical	lymph	nodes	without	an	identified	primary	site.	The	
patients	 were	 first	 evaluated	 in	 the	 outpatient	 setting	 and	 had	
negative	 findings	 on	 physical	 exam,	 flexible	 laryngoscopy,	 and	
PET-CT.	To	fit	our	inclusion	criteria	for	unknown	primary	based	
on	PET-CT,	the	imaging	study	had	to	be	entirely	negative	with-
out	any	 suggestion	of	a	primary	 site.	Further	 inclusion	criteria	
required	patients	to	have	undergone	LT	in	addition	to	standard	
staging	 laryngoscopy/palatine	 tonsillectomy	 as	 part	 of	 their	
diagnostic	workup.	LT	could	have	been	performed	concurrently	
with	standard	staging	laryngoscopy/palatine	tonsillectomy,	or	as	
a	second	procedure.
For	all	three	approaches,	the	LT	is	performed	by	first	making	
an	 incision	 along	 the	 lateral	 base	of	 tongue	 and	 then	 carefully	
dissecting	the	lingual	tonsillar	tissue	off	the	fold	and	tongue	mus-
culature.	Dissection	is	carried	down	to	the	vallecula,	the	midline	
of	the	tongue	base,	and	up	to	the	circumvallate	papillae	and	fora-
men	cecum.	The	specimen	is	removed	en	bloc.	The	lingual	tonsils	
are	removed	separately.	After	the	tonsillar	tissue	is	oriented	with	a	
suture,	it	is	submitted	for	permanent	pathologic	analysis.
For	TORS	procedures,	the	da	Vinci	S	or	da	Vinci	Xi	system	is	
utilized.	Exposure	of	the	lingual	tonsil	is	achieved	by	retracting	
the	oral	tongue	forward	and	placing	a	Crowe–Davis	retractor.	A	
30°	12 mm	(da	Vinci	S)	or	8 mm	(da	Vinci	Xi)	telescope,	a	com-
bination	of	Maryland	and	Schertel	graspers,	and	Bovie	cautery	
attachments	are	utilized.
For	 TLM	 and	 transoral	 microsurgery	 with	 cautery	 (TMC)	
procedures,	 exposure	 is	 similar	 utilizing	 either	 the	 Lindholm	
operating	laryngoscope	or	by	retracting	the	tongue	forward	and	
placing	a	Crowe–Davis	retractor.	Visualization	is	achieved	with	
an	operating	microscope	(TLM	and	TMC)	or	laryngeal	telescope	
(TMC).	For	TLM,	a	CO2	laser	attached	to	a	micromanipulator	on	
the	microscope	is	used	whereas	for	TMC,	a	bovie	cautery	with	an	
extended	spatula	tip	is	used.
search strategy
A	systematic	review	of	published	reports	on	LT	for	the	workup	of	
CUP	was	performed	from	June	2015	to	March	2018	on	MEDLINE,	
Cochrane	Central	Register,	and	CINAHL	for	all	relevant	English-
language	studies.	Before	June	2015,	a	systematic	review	from	Fu	
et al.	 (19)	was	used.	Keywords	and	subject	headings	specifying	
unknown	 primary,	 LT,	 SCC,	 and	TORS	 or	 TLM	were	 used	 to	
identify	studies.	Studies	that	included	less	than	five	patients	were	
Table 1 | Patient demographics and comorbidities.
age (years) Tobacco abuse Tobacco abuse etOh abuse comorbidities
Case 1 56–60 40 packs/year 40 packs/year 6 drinks/day None
Case 2 56–60 None None None None
Case 3 56–60 None None None None
Case 4 61–65 40 packs/year 40 packs/year None T2DM, prostate CA, HTN, obesity
Case 5 66–70 40 packs/year 40 packs/year None Stroke, CAD, HTN, HLD, atrial flutter
Case 6 41–45 25 packs/year 25 packs/year None Anxiety, depression
Case 7 66–70 None None 2 drinks/day Hearing loss
Case 8 56–60 None None None None
Case 9 51–55 10 packs/year 10 packs/year None None
Case 10 46–50 None None None HLD, asthma
Case 11 51–55 20 packs/year 20 packs/year 1 drink/day T1DM, osteoarthritis
Table 2 | Patient nodal status, surgery, and results.
nodal 
status
surgery lingual tonsil concurrent neck 
dissection
Tumor size Margins p16
Case 1 R N2a Transoral laser microsurgery (TLM) CO2 Positive N 0.5 cm × 0.4 cm Negative Negative
Case 2 R N2 TLM CO2b Negative Y N/A N/A Positive
Case 3 R N2 TLM CO2 Negative N N/A N/A Positive
Case 4 L N2 TLM CO2 Negative Y N/A N/A Positive
Case 5 L N3 TLM CO2b Negative Nc N/A N/A Negative
Case 6 L N2 TLM CO2 Negative N N/A N/A Positive
Case 7 L N1B TLM CO2 Positive N Small foci Negative Positive
Case 8 R N2 Transoral robotic surgery (TORS)b Negative N N/A N/A Positive
Case 9 R N2 TORSb Negative Y N/A N/A Positive
Case 10 R N2 Transoral microsurgery with cautery (TMC) Negative Nc N/A N/A Positive
Case 11 R N2 TMCb Positive Nc Undetermined Positive: deep 
margin
Positive
Case 12 R N2 TORS Negative Y N/A N/A Positive
Case 13 L N2 TORSb Positive Y 0.3 cmd Negative Positive
Case 14 L N2 TORS Negative Y N/A N/A Positive
Case 15 R N2 TORSb Negative Y N/A N/A Negative
Case 16 R N2 TMCb Negative N N/A N/A Negative
aLiver and axillary metastasis.
bBilateral lingual tonsillectomy.
cNeck dissection as a second procedure.
dIn the largest diameter.
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excluded.	These	studies	also	had	to	provide	data	on	the	number	of	
patients	who	did	not	have	suspicious	findings	on	clinical	workup	
and	subsequently	had	an	LT.
resUlTs anD analYsis
Between	 February	 2010	 and	May	 2017,	 16	 patients	met	 inclu-
sion	criteria	and	underwent	TORS,	TLM,	or	TMC	LT.	Of	the	16	
patients,	13	were	male	(81%).	The	ages	ranged	from	42	to	71,	with	
a	mean	age	of	59.	Nine	of	the	patients	used	tobacco	and	six	of	the	
patients	reported	daily	alcohol	use.	One	patient	had	a	history	of	
both	basal	cell	carcinoma	on	his	scalp	and	prostate	cancer	with	no	
evidence	of	disease	since	prostatectomy	in	2011.	The	remaining	
patients	denied	any	previous	malignancy.	Demographic	details	of	
these	patients	are	depicted	in	Table 1.
clinical Workup
Fifteen	patients	presented	with	a	 level	 II	and/or	 level	 III	cervi-
cal	node,	and	one	patient	presented	with	a	 level	I	 lymph	node.	
There	were	no	 localizing	ENT	 symptoms,	 and	 all	 patients	 had	
negative	 findings	 on	 physical	 exam	 and	 flexible	 laryngoscopy.	
All	 FNA/core	 biopsies	 of	 the	metastatic	 nodes	 identified	 SCC,	
75%	of	which	were	p16	positive	(Table 2).	All	patients	underwent	
preoperative	PET-CT,	none	of	which	showed	evidence	of	primary	
tumor	localization.
surgical approach
Lingual	 tonsillectomy	was	 performed	 either	 during	 the	 stand-
ard	 staging	 laryngoscopy	 (7/16)	 or	 as	 a	 secondary	 procedure	
(9/16)	with	8	patients	 receiving	bilateral	LT.	Unilateral	LT	was	
performed	in	patients	undergoing	concurrent	palatine	tonsillec-
tomy	and	was	intended	to	minimize	the	small	theoretical	risk	of	
oropharyngeal	stenosis	resulting	from	circumferential	denuding	
of	mucosa	(20).	Seven	patients	had	their	palatine	tonsils	removed	
for	unrelated	reasons	before	their	current	presentation.	LT	was	
performed	using	TORS	(6/16),	TLM	(7/16),	or	TMC	(3/16)	with	
a	detection	 rate	of	 25%	 (4/16).	All	detectable	 carcinomas	were	
found	on	 the	 ipsilateral	 side	of	 the	presenting	 lymph	node.	Of	
the	four	detectable	carcinomas,	one	was	0.5 cm × 0.4 cm	in	size,	
a	second	was	0.3 cm	in	its	largest	diameter,	a	third	was	too	small	
for	measurement	but	had	a	small	focus	of	cancerous	cells,	and	the	
fourth	extended	into	the	deep	margin	with	a	surface	epithelial	to	
Table 3 | Postoperative care and follow-up.
adjuvant 
therapy
Disease 
status
surgery to last follow-up 
(months)
Case 1 RT AWD 8.7
Case 2 RT NED 23.6
Case 3 CRT NED 21.7
Case 4 CRT NED 12.3
Case 5 None NED 7.1
Case 6 CRT NED 52.6
Case 7 CRT NED 38.2
Case 8 CRT DSD 30.7
Case 9 CRT NED 27.5
Case 10 None NED 12.4
Case 11 RT NED 5.5
Case 12 None NED 84.3
Case 13 RT NED 3.6
Case 14 None NED 19.9
Case 15 None NED 9.8
Case 16 CRT NED 6.5
RT, radiation therapy; CRT, chemoradiation; AWD, alive with disease; NED, no evidence 
of disease; DSD, died without disease.
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deep	margin	measurement	of	0.5 cm.	Three	of	the	four	carcino-
mas	were	p16	positive	(Table 2).
complications
Although	three	patients	develop	bleeding	postoperatively,	none	
of	the	bleeding	was	associated	with	the	LT.	One	patient	required	
reoperation	for	bleeding	from	the	palatine	tonsil	on	postopera-
tive	day	(POD)	6.	This	patient	took	apixaban	on	POD	5	due	to	
a	 history	 of	 atrial	 flutter	 and	 stroke.	A	 second	patient	 had	 an	
expanding	hematoma	after	neck	dissection	immediately	postop	
and	required	operative	management.	A	third	patient	presented	
to	the	Emergency	Department	for	a	palatine	tonsillar	bleed	on	
POD	12,	which	was	 treated	with	 topical	 silver	nitrate	 cautery.	
All	16	patients	were	able	to	tolerate	a	soft	diet	at	the	first	post-
operative	visit,	and	no	patients	had	any	significant	weight	loss.	
No	patients	required	a	G-tube	following	surgery.	Three	patients	
noted	 taste	 disturbances	 following	 surgery	 that	 improved	 on	
follow-up.	There	were	no	other	complications	from	TORS,	TLM,	
or	TMC	LT.
Follow-Up
Follow-up	ranged	from	3.6 months	to	almost	7 years	after	LT	with	
an	average	 follow-up	of	3.5 years.	Following	LT,	 seven	patients	
received	CRT,	and	four	patients	received	only	radiotherapy.	Five	
patients	elected	to	clinically	monitor	their	status	without	chemo-
therapy	or	radiotherapy.	Fourteen	patients	on	last	follow-up	are	
alive	without	evidence	of	disease	(Table 3).	One	patient	developed	
recurrence	in	the	right	neck	at	levels	IV	and	V,	with	spread	to	the	
liver	and	axilla	4 months	after	completion	of	radiotherapy.	This	
patient	was	1	of	4	cases	that	had	a	p16-negative	carcinoma.	She	
was	a	heavy	smoker	(40	pack/years)	and	heavy	drinker	(6	drinks/
day)	who	continued	 to	 smoke	after	diagnosis	and	surgery.	The	
final	patient,	 in	whom	a	primary	cancer	was	never	found,	died	
from	acute	myeloid	leukemia,	3 years	after	his	initial	LT	with	no	
evidence	of	recurrence	of	his	UPHNC.
The	systematic	review	from	Fu	et al.	identified	a	total	of	eight	
studies,	three	of	which	had	less	than	five	patients,	and	two	studies	
did	not	provide	enough	data	on	lingual	tonsillectomies	performed	
after	a	completely	negative	workup	and	were	excluded.	On	 the	
literature	search	from	June	2015	to	March	2018,	four	studies	were	
identified.	Of	the	four	papers,	one	was	the	systematic	review	from	
Fu	et al.,	 and	a	 second	 focused	on	radiotherapy	characteristics	
and	outcomes,	and	the	last	two	did	not	include	enough	data.	After	
review,	three	studies	were	included	in	our	analysis.
DiscUssiOn
Although	not	always	possible,	identification	of	the	site	of	origin	
for	unknown	primary	SCC	is	an	essential	goal	for	the	head	and	
neck	surgeon.	Radiotherapy	increases	patient	morbidity	with	side	
effects	 such	 as	 xerostomia,	 dysphagia,	 and	odynophagia;	when	
treatments	can	be	targeted	to	an	identified	location,	patient	mor-
bidity	is	reduced.	In	addition,	 in	select	patients,	treatment	may	
consist	of	resection	alone	with	avoidance	of	radiation	depending	
on	pathology	 and	margin	 status.	Thus,	methods	 for	 increasing	
primary	site	identification	are	of	great	interest.
While	 there	 is	 currently	 no	 universal	 guideline	 for	workup	
of	 unknown	 primary	 SCC	 of	 the	 head	 and	 neck,	 a	 national	
guideline	is	present	in	the	United	Kingdom.	Typically,	a	workup	
starts	with	 a	 full	 history	 and	physical	 exam	with	flexible	 fiber	
optic	laryngoscopy.	PET-CT	is	often	incorporated	and	presents	
a	diagnostic	rate	ranging	from	7	to	38%	(7,	8).	However,	a	major	
limitation	 of	 PET-CT	 is	 that	 tumors	 less	 than	 1  cm	 in	 diam-
eter	are	not	 reliably	detected	 (21).	 In	a	 study	of	111	 identified	
unknown	primary	 tumors,	 the	 average	 diameter	was	 1.15  cm,	
and	57%	of	tumors	were	less	than	1 cm	in	diameter	(19).	These	
data	 suggest	 that	more	 than	half	 of	unknown	primary	 tumors	
may	be	below	PET-CT	detection	level,	and	their	reported	value	
may	 be	 an	 underestimation	 since	 tumors	 included	were	 those	
able	to	be	identified	with	imaging	or	panendoscopy.	Despite	this,	
Mackenzie	et al.	and	the	United	Kingdom	National	Guidelines	
recommend	that	all	patients	presenting	with	confirmed	cervical	
lymph	node	metastatic	SCC	and	no	identifiable	primary	should	
undergo	PET/CT	(22).
Once	 imaging	 is	 complete,	 panendoscopy	 with	 tumor	
mapping	 is	 traditionally	 performed.	When	PET-CT	 is	 able	 to	
provide	 targeted	 biopsies,	 diagnostic	 rates	 of	 tumor	mapping	
range	 from	 20	 to	 50%	 (5,	 6,	 9,	 10).	 However,	 when	 physical	
exam	and	PET-CT	are	negative,	diagnostic	rates	decrease	 to	a	
range	of	9–29%	(5,	10).	Depending	on	the	institution,	palatine	
tonsillectomy	may	be	performed	during	panendoscopy	and	has	
been	shown	to	provide	cancer	detection	rates	superior	to	biopsy	
of	tonsillar	tissue	alone	(23).
In	recent	years,	LT	performed	with	TLM	and	TORS	has	shown	
promising	results	at	increasing	UPHNC	detection	with	rates	rang-
ing	from	18	to	90%.	The	dramatic	differences	in	detection	rate	are	
likely	secondary	to	small	cohorts	in	all	studies,	a	consequence	of	
infrequent	presentation.	We	 report	 an	overall	detection	 rate	of	
25%	with	LT.	This	detection	rate	 is	 lower	than	most	previously	
reported	studies,	but	 this	 is	most	 likely	 secondary	 to	our	strict	
inclusion	criteria.	For	the	16	patients	in	our	study,	there	could	be	
absolutely	no	suspicious	findings	on	physical	exam	or	PET-CT,	
and	panendoscopic	biopsies	must	all	have	been	negative.
In	 a	 study	 by	 Mehta	 et  al.,	 LT	 with	 TORS	 yielded	 a	 90%	
detection	rate;	however,	40%	of	these	had	positive	BOT	PET-CT	
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findings,	 20%	of	which	were	positive	 in	 the	BOT	 ipsilateral	 to	
imaging,	and	20%	were	positive	on	the	contralateral	BOT	accord-
ing	to	imaging	(1).	In	a	multi-institutional	study	by	Patel	et al.,	
palatine	and	LT	using	TORS	together	resulted	in	72.3%	(34/47)	
tumors	identified	(14).	For	LT	alone,	the	isolation	rate	was	42.6%	
(20/47).	However,	in	this	study	48.9%	of	patients	had	suspicious	
physical	 exam	 findings,	 56.5%	 of	which	were	 confirmed	 to	 be	
cancer,	 and	34%	of	which	had	 suspicious	findings	on	PET-CT,	
50.0%	of	which	were	 confirmed	 to	be	malignancy.	Nagel	 et  al.	
performed	LT	on	14	patients,	57%	(8/14)	of	which	were	positive,	
but	it	was	not	indicated	whether	imaging	took	place	prior	(17).	It	
is	likely	that	these	rates	of	successful	diagnosis	are	higher	than	our	
cohort	secondary	to	inclusion	of	patients	who	had	either	suspi-
cious	exam	findings	or	positive	PET-CT	findings,	which	would	
both	increase	the	likelihood	of	included	tumors	being	larger	in	
size	and	thus	easier	to	isolate.
However,	 a	 counterpoint	 would	 be	 that	 PET-CT	 carries	 a	
false	positive	rate	up	to	37%,	thus	patients	with	positive	PET-CT	
findings	 could	 still	 be	 considered	 unknown	 primary	 (7).	
Furthermore,	in	a	study	by	Durmus	et al.,	of	the	22	patients	who	
underwent	either	a	combination	of	palatine	tonsillectomy	with	
LT,	LT	alone,	radical	tonsillectomy,	or	base	of	tongue	resection	
with	TORS,	lingual	tonsils	were	positive	in	4/22	(18%)	of	cases	
(18).	This	study	presents	a	detection	rate	lower	than	that	of	our	
study,	yet	nine	patients	(40.9%)	had	PET-CT	findings	confirmed	
by	surgical	resection.	Granted,	most	of	these	were	positive	pala-
tine	tonsils.
Most	 recently,	 a	 systematic	 review	 by	 Fu	 et  al.	 reported	 LT	
identifying	primary	tumor	in	72%	(18/25)	patients	with	no	find-
ings	(19).	The	cohort	size	included	in	the	systematic	review	was	
limited	 by	 heterogeneity	 of	 preoperative	 workups,	 definitions	
of	 unknown	primary,	 and	 limited	 information	 regarding	 exact	
surgical	techniques	utilized	in	the	literature.	A	prospective,	multi-
institutional	 trial	 utilizing	 homogenous	 preoperative	 workup,	
imaging,	and	surgical	 techniques	would	be	required	 to	present	
an	accurate	UPHNC	diagnosis	from	LT.
In	 accordance	 with	 current	 changes	 in	 the	 epidemiological	
landscape	 in	 oropharyngeal	 SCC,	 the	 majority	 of	 neoplasms	
(75%)	in	this	study	were	p16	positive	(24).	Although	conclusions	
cannot	be	drawn	based	on	low	sample	size,	the	detection	rate	of	
p16	positive	tumors	was	higher	than	that	of	p16-negative	tumors,	
rates	being	75	and	25%,	respectively.
Despite	a	 large	range	of	 tumor	 isolation	reported	 from	LT,	
it	is	a	useful	adjunct	in	UPHNC	identification	and	carries	low	
risk	 of	morbidity.	The	most	 common	 adverse	 event	 from	 LT	
is	 postoperative	 bleeding	 in	 5%	 of	 cases	 (19).	 In	 this	 study,	
although	three	patients	had	bleeding	events	after	surgery,	none	
were	related	to	the	LT	itself.	Given	that	all	reported	LT	UPHNC	
diagnostic	 rates	 exceed	 this	 value,	 it	 may	 be	 reasonable	 to	
perform	 LT	 at	 the	 time	 of	 panendoscopy	with	 intent	 to	 save	
the	patient	a	separate	surgery	and	potentially	expedite	diagnosis	
and	treatment.
The	primary	weakness	of	this	study,	one	shared	among	all	of	
the	existing	literature,	is	a	small	patient	cohort.	The	uncommon	
presentation	of	unknown	primary	SCC	in	the	head	and	neck	in	
addition	to	our	strict	criteria	were	some	of	the	reasons	explaining	
the	number	of	patients	included	in	our	study.	After	the	literature	
review,	only	three	studies,	namely,	Mehta	et al.	(1),	Patel	et al.	
(14),	 and	 Nagel	 et  al.	 (17),	 provided	 enough	 information	 to	
determine	an	identification	rate	for	LT	after	a	negative	clinical	
workup,	including	an	absence	of	suspicious	findings	on	PET-CT,	
panendoscopy	with	biopsies,	and	palatine	tonsillectomy.	When	
all	 suspicious	findings	were	excluded,	43	cases	 from	the	 three	
studies	 remain,	 with	 34	 receiving	 LT	 (Table  4).	 Although	 a	
small	patient	cohort	is	present,	it	is	similar	to	other	studies	and	
increases	the	number	of	patients	with	a	negative	clinical	workup	
and	subsequent	LT	by	almost	50%.	Another	potential	weakness	
of	 this	 study	 is	 that	 three	 differing	 resection	 techniques	were	
utilized,	 although	 successful	 identification	 of	 a	 primary	 was	
achieved	with	each	technique.	Of	note,	seven	patients	had	a	neck	
dissection	 concurrent	 with	 the	 tonsillectomy,	 three	 patients	
had	a	neck	dissection	as	a	second	procedure,	and	six	elected	to	
not	have	a	neck	dissection.	The	differences	in	practice	patterns	
were	 largely	 a	 result	 of	 recommendations	 from	 tumor	 board,	
dependent	on	the	characteristics	of	the	metastatic	node	and	if	
the	patient	elected	to	receive	adjuvant	therapy.	Finally,	in	eight	
patients,	LT	was	only	performed	on	the	side	of	the	presenting	
nodal	metastasis.	While	unilateral	LTs	were	performed	to	reduce	
patient	morbidity,	 reported	 rates	 of	 unknown	 primary	 in	 the	
contralateral	lingual	tonsil	are	10%	(18).
Table 4 | Proportion of patients without suspicious findings on diagnostic workup and identification in the lingual tonsil.
reference institution Proportion with 
suspicious findings
Proportion without suspicious 
findings on PeT/cT, eUa with biopsy, 
and palatine tonsillectomy
identification in 
lingual tonsil after 
negative workup
Mehta et al. (1) University of Pittsburgh Medical Center 4/10 6/10 5/6
Patel et al. (14) University of Washington Medical Center 32/47 15/47 8/14
MD Anderson Cancer Center
University of Alabama Birmingham
University of Texas Medical School at Houston
Johns Hopkins Hospital
Oregon Health & Sciences University
Nagel et al. (17) Mayo Clinic Arizona 30/52 22/52 8/14
Sudoko et al. (the 
current study)
Dartmouth-Hitchcock Medical Center 0/16 16/16 4/16
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The	rate	of	unknown	primary	detection	from	LT	in	patients	
with	a	negative	PET/CT	was	25%.	The	rate	of	unknown	primary	
detection	from	LT	in	the	literature	ranges	from	18	to	90%,	although	
cohort	size	is	a	limitation	of	all	existing	studies.	Nevertheless,	LT	
improves	unknown	primary	site	identification	and	carries	low	risk	
of	complications	and	therefore	should	be	advocated	in	the	diag-
nostic	algorithm	for	UPHNC	to	minimize	treatment	morbidity.
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